Cargando…
Synthesis, in vitro Antileishmanial Efficacy and Hit/Lead Identification of Nitrofurantoin‐Triazole Hybrids
Leishmaniasis is a vector‐borne neglected parasitic infection affecting thousands of individuals, mostly among populations in low‐ to moderate‐income developing countries. In the absence of protective vaccines, the management of the disease banks solely on chemotherapy. However, the clinical usefuln...
Autores principales: | Zuma, Nonkululeko H., Aucamp, Janine, Viljoen, Maryna, N'Da, David D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322565/ https://www.ncbi.nlm.nih.gov/pubmed/35388649 http://dx.doi.org/10.1002/cmdc.202200023 |
Ejemplares similares
-
Design, synthesis, electrochemistry and anti-trypanosomatid hit/lead identification of nitrofuranylazines
por: Saayman, Maryna, et al.
Publicado: (2023) -
Exploring novel nitrofuranyl sulfonohydrazides as anti‐Leishmania and anti‐cancer agents: Synthesis, in vitro efficacy and hit identification
por: Kannigadu, Christina, et al.
Publicado: (2022) -
In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs
por: Munsimbwe, Linous, et al.
Publicado: (2021) -
A Triazole Hybrid of Neolignans as a Potential Antileishmanial Agent by Triggering Mitochondrial Dysfunction
por: Cardozo Pinto de Arruda, Carla, et al.
Publicado: (2019) -
Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
por: Koovits, Paul J., et al.
Publicado: (2020)